CLINICAL_TRIALS
trial_result
· 2014-01-07
Clinical Trial Update: Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery [Phase 2]
Summary
Phase 2 trial update showing results for sunitinib in unresectable kidney cancer (renal cell carcinoma); results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Case Comprehensive Cancer Center | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-01-07